Shock Wave Therapy Versus Low Level Laser Therapy in Patients With Plantar Fasciitis

February 20, 2024 updated by: Reham Mohamed Lotfy Soliman, Cairo University

Effect of Shock Wave Therapy Versus Low Level Laser Therapy in Patients With Plantar Fasciitis

Both shock wave therapy and low level laser therapy in plantar fasciitis are effective in improvement of such cases without any side effects but there are no previously published studies on the use of shock wave therapy versus low level laser therapy in plantar fasciitis and, hence, evidence of its acceptability and effectiveness compared with each other remains to be established.

Study Overview

Detailed Description

Plantar fasciitis is a result of degenerative irritation of the plantar fascia origin at the medial calcaneal tuberosity of the heel as well as the surrounding perifascial structures, it is a common problem accounting for approximately one million patient visits per year, it is often an overuse injury. As a result tight gastrocnemius, soleus, and/or other posterior leg muscles have also been commonly found in patients with this condition.

Shock wave therapy is thought to provide long lasting analgesia and stimulate the healing process, Low level laser therapy has been used to relieve pain caused by plantar fasciitis, also stretching of the shortened and contracted plantar flexors may positively influence an individual's functional activities of daily living and decrease the risk of injury.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Giza, Egypt
        • Reham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age ranges from 40-60 years old.
  2. Both genders will be included.
  3. Unilateral plantar fasciitis.
  4. Duration of symptoms more than 4 weeks.
  5. Positive Windlass test and negative Tinel and calcaneus squeeze tests.
  6. Patients will be classified according to their BMI (18.5 - 24.9) kg/m2

Exclusion Criteria:

  1. Open wound, infection in plantar surface of foot.
  2. History of foot surgery.
  3. History of trauma or fracture in foot or ankle.
  4. Neuropathic pain as diabetes mellitus.
  5. Peripheral vascular disease.
  6. Calcaneal stress fracture or show evidence of a foreign body or tumor of the affected heel.
  7. Previously suffered a rupture or surgery of the plantar fascia. Existing or prior osteomyelitis of the involved calcaneus.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
conventional physical therapy program (Instructions, Ice application, Deep tissue massage, Stretching exercises, Joint mobilization and isometric exercises).
conventional therapy ( instructions, ice application, deep tissue massage, stretching exercises, joint mobilization and isometric exercises )
Experimental: Experimental group 1
Shock wave therapy + Conventional physical therapy.
conventional therapy ( instructions, ice application, deep tissue massage, stretching exercises, joint mobilization and isometric exercises )
Acoustic waves (shock waves) that can carry energy and can propagate through tissues promote healing effects.
Experimental: Experimental group 2
Low level laser therapy + Conventional physical therapy.
conventional therapy ( instructions, ice application, deep tissue massage, stretching exercises, joint mobilization and isometric exercises )
The application of light to a biologic system to promote tissue regeneration, reduce inflammation and relieve pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess the change in pain intensity level
Time Frame: Before treatment and after 6 weeks treatment
The visual analogue scale (VAS) is a widely utilized pain intensity level assessment instrument in patients with plantar fasciitis. The visual analogue scale (VAS) is typically composed of a horizontal line from zero (minimum value) to 10 (maximum value) where zero signifies (no pain) and 10 signifies (worst pain) one can imagine.
Before treatment and after 6 weeks treatment
Assess the change in pain pressure threshold
Time Frame: Before treatment and after 6 weeks treatment
Pressure algometry will be used to evaluate the pain pressure threshold for the two predetermined locations on the affected leg: gastrocnemius (middle point over the muscle belly) and soleus (center point of the muscle belly 10 cm above the Achilles tendon). The participant will speak up at the point where the pressure evoke a painful sensation. This process will be repeated 3 times in the same manner, and three measurements will be recorded at the same point on the plantar fascia. An average of the three readings will be recorded. Higher algometer scores indicate greater pressure threshold, therefore less tenderness. Lower algometer scores indicate less pressure threshold, thus more tenderness.
Before treatment and after 6 weeks treatment
Assess the change in range of ankle motion
Time Frame: Before treatment and after 6 weeks treatment
Ankle range of motion (ROM) will be measured by using digital goniometer (ankle dorsiflexion and plantarflexion ranges will be measured). It can monitor the progress of intervention.
Before treatment and after 6 weeks treatment
Assess the change in foot functional disability
Time Frame: Before treatment and after 6 weeks treatment
Foot functional disability will be assessed by foot and ankle ability measure questionnaire (FAAM). Higher scores on the questionnaire indicate a higher level of physical functioning and lower scores on the questionnaire indicate a lower level of physical functioning.
Before treatment and after 6 weeks treatment
Assess the change in ankle stability
Time Frame: Before treatment and after 6 weeks treatment
The Human Assessment Computer (HUMAC) Balance System will be used in the current study to assess limits of stability of ankle joint.
Before treatment and after 6 weeks treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Fatma S Amin, Professor, Cairo University
  • Study Director: Rania N Karkousha, Ass.prof, Cairo University
  • Study Director: Mohamed I Abd Elhay, Lecturer, Cairo University
  • Study Director: Ashraf N Moharram, Professor, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

October 10, 2023

Study Completion (Actual)

October 10, 2023

Study Registration Dates

First Submitted

April 29, 2023

First Submitted That Met QC Criteria

May 10, 2023

First Posted (Actual)

May 22, 2023

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/004154

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plantar Fascitis

Clinical Trials on conventional therapy

3
Subscribe